Targeting T Cell Subtypes for NAFLD and NAFLD-Related HCC Treatment: An Opinion
Guardado en:
Autores principales: | Chunye Zhang, Ming Yang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8992b8faf0db411aba01e0f7df18e05e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Correlation between Non-Alcoholic Fatty Liver Disease (NAFLD) fibrosis score (NFS) with Left Ventricular Mass Index (LVMI) in patients with NAFLD
por: Tri Ferry Rachmatullah, et al.
Publicado: (2021) -
Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC
por: Paola Dongiovanni, et al.
Publicado: (2021) -
COMPARISON OF SERUM FERRITIN LEVELS IN NAFLD PATIENTS AND HEALTHY CONTROLS
por: Mehwish Qamar, et al.
Publicado: (2020) -
Editorial: New Insights Into Understanding and Managing NAFLD
por: Óscar Escribano, et al.
Publicado: (2021) -
Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLD
por: Stefania Di Mauro, et al.
Publicado: (2021)